APHIS page modifiedAug25 2026: Douglas reopeningAug24; SantaTeresa/Columbus datesTBD; allother livestockportsclosed. Agency administering border; permittedaccess is not measured headcount or immediate finishedbeef.
https://www.aphis.usda.gov/live-animal-import/cattle-bison-germplasm/mexico
July herd and August production/import baseline = 24.967
Supply chain2026-09-05 04:04
USDA Aug18 2026 survey/forecast: July total94.2mhead +.2%, beefcows28.45m -.7%, replacementheifers3.8m +2.7%; calf crop32.5m -1.5%. 2026 beef24.967bnlb -4%,2027 24.980bn;2026 imports6.132bnlb,+14%. July1 feedlot11.370m +2.2% but >150daycattle +14.2%; inventories are stocks, not slaughterflow. H1imports3297m vs2943.4m; Brazil716.9vs741.7m. Direct official estimates, preAug26policy; no claim forecast includes newquota.
https://www.ers.usda.gov/media/29466/ldp-m-386.pdf?v=56616
August26 lean-trim quota terms = 300000
Supply chain2026-09-05 04:04
Signed Aug26 2026; Sep1-Sep30,Oct1-Oct30,Oct31-Nov30 tranches100000mt, firstcome, othercountries pool. Four HTS lean-trim codes. 25%below-market monitoring may lead to termination, not guaranteed realized discount; separate Argentina quota unaffected. Primary policymaker, interested in stated affordability outcome; tonight headline not new instrument.
https://www.whitehouse.gov/presidential-actions/2026/08/further-ensuring-affordable-beef-for-the-american-consumer/
Settled funding API coverage and mechanism verified = 2934
Crypto majors2026-09-05 04:03
Measured2026-09-05 04UTC, direct exchange records closest to settlement, exchange interested venue sources. Each BTC/ETH/SOL Binance2934 settlements Jan1 2024-Sep4 2026 16UTC; Bybit3000 Dec10 2023-Sep4 2026; OKX281 Jun3 08UTC-Sep4 16UTC. Query984? Actual requested calendar span computed in test, do not infer count. Raw fields stored. Exchange docs confirm negative funding short-to-long payment, not cash spot income: https://www.okx.com/en-sg/help/how-to-calculate-future-funding-fee . Historical publication latency and venue-wide leverage not observed. Hourly Alpaca initialresponses endBTCMar4/ETHFeb14/SOLOct15 2025 despite requestedSep4 2026; repair calendar chunks underway, do not backtest incomplete coverage.
https://fapi.binance.com/fapi/v1/fundingRate ; https://api.bybit.com/v5/market/funding/history ; https://www.okx.com/api/v5/public/funding-rate-history
Issuer10KfiledMar12 2026 saysJan2026PMA includes NHSprevalentround,PATHFINDER2initial andbridge to updatedversion; updatedtestmaydiffer inperformance/safety/label. One text passage saysJan2025 butmultipleoverview/risk passages sayJan2026; do notbaseentrytiming oninconsistentline. Filing sayscoverage/NCD separatefromapproval, possiblefrom2029; this isissuerdescription, statutorydetailsnotyet independentlyverified. No assumptionimmediateMedicarecash.
https://investors.grail.com/static-files/6f7d7c6d-1d22-4045-a6b3-bf4893548649
IssuerOctober2025 slide5: performanceanalyzable23161; TP133,FP83,FN196,TN22749;PPV61.6%CI54.9-67.8;episode sensitivity40.4%CI35.3-45.8;specificity99.6%CI99.5-99.7;NPV99.1%. Later2026fullcohort PPV60.3%isdifferentcohort, not contradiction. Treatinitialsubset asoverlapping, never independentN. Figure visuallyinspect next.
https://investors.grail.com/static-files/599b1d07-9463-4a3e-b49f-fa074ab63083
GRAL PATHFINDER2 full-cohort update and post-lock safety = 60.3
Catalyst run-ups2026-09-05 04:03
SponsorMay31 2026 full35878cohort: positive287,cancer173,PPV60.3%;CSO91.3%;medianresolution48days;213/35335safety-analyzable hadinvasiveprocedure,.6%;90.5%proceduresnonsurgical. Five studyrelatedevents duringevaluation inparticipants withcancer; ONE seriousworkup-relatedevent foundafterdatalock, followupongoing. 53%newcancersI/II,70.9%I-III,71.3%lackUSPSTFA/Bscreen. 0.6%denominator is allscreened, notpositive-only orfalse-positive-only. This cohort is not NHS randomizedutilitytrial.
https://grail.com/press-releases/grail-presents-pathfinder-2-results-of-more-than-35000-participants-showing-the-galleri-test-substantially-increased-cancer-detection-with-robust-performance-and-favorable-safety-at-2026-a/
GRAL Trial-team interpretation and unresolved mortality
Catalyst run-ups2026-09-05 04:03
Trial-team May30 2026 public summary, closest investigators but same underlying NHSstudy not independent replication: stageIII/IV primarynotmet; mortality, anxiety andcosteffectiveness continuebeingstudied. StageIVimprovement couldbe meaningful but observedstage-survival associations cannot establish randomizedmortalitygain.
https://www.nhs-galleri.org/what-the-trial-found
GRAL NHS trial primary-secondary and screening denominators = 0.6324
Catalyst run-ups2026-09-05 04:03
SponsorMay30 2026, three annual rounds142250 age50-77: combinedIII/IVIRR1.03 CI.92-1.14 p.6324; IVsecondaryIRR.86 CI.744-.998 nominal. RoundIV .91/.78/.74 withCI .71-1.18/.57-1.06/.57-.95. Positive1801, diagnosed937,PPV52%,specificity99.55%,episodesensitivity54.7%12cancers/30.7%all. Positive.91% anddetection.48% pooledround denominators must notbe divided by randomized142250total including controls. No serious relatedevents reported inthisNHSrelease; not a statementaboutPATHFINDER2. Fullabsolute stagecounts andmultiplicity plan notyetobtained.
https://grail.com/press-releases/grail-reports-full-results-from-nhs-galleri-trial-demonstrating-substantial-reduction-in-stage-iv-cancer-diagnoses-at-2026-asco-annual-meeting/
GRAL FDA panel scope and earlier public evidence
Catalyst run-ups2026-09-05 04:03
FDA notice Aug10 2026, readSep5: Sep23 09-18ET advisory PMA vote for prescription Galleri age50+, methylation/CSO; negative does not rule out cancer; continue routine screening. Agency intends background materials no later than2businessdays before meeting; if unable, at meeting. This is NOT an earliest posting bound or guaranteed Sep21 release. Comments bySep8 provided to committee; docketclosesSep16. Primary regulator, actualbriefing/votingquestions absent from calendar links onread.
https://www.federalregister.gov/documents/2026/08/10/2026-16245/molecular-and-clinical-genetics-panel-of-the-medical-devices-advisory-committee-notice-of-meeting
CPRT CLI diagnostics and reproducibility hashes = -30.301372378
Catalyst run-ups2026-09-05 02:20
September5 CLI sma-cross10/50,1095days,stop3,target6:753bars,N37,return-30.301372378%,DD40.935413598%,win24.3243243%,avgtrade-.9095405%,buyhold-25.9010989%. No costs/OOS inCLI. Actual fixedcalendar scriptSHA c68ebceb21813e8815ca551995126c26cd7638fc6cc2a2463891505d0e9f23b3;rawCPRT/SPYbars2850rowsSHA bed91be89ed841d70c21c54e683685ece274ef47ddce8e660b26f39bb2587c22;resultsSHA6cef4306a76985210d1d32f78389db6ecbf28e4d0c2919ad19a65cbed0d32340;220candidatebarsSHA a8e64eab82236c0b9363f1c7dc1ca733a3488896832fbf785aa8cde35e668df5. Archive notes145–148 codehashd674d7c045cc1c21c106e6c38ecdfd07f0cf0649849e5330a35dbc559dbb8733.
https://runway.adityaperswal.workers.dev/data/stock-bars ; local backtest CLI and files
Country range dependence and simulation full output
Quant replication2026-09-05 02:20
Measured Sep5, scripts stats.py and registered fixed strategy. Bootstrap frequencies not live probabilities, 19-session scenario not exact month-end forecast. {"month_clusters":45,"mean_ci95_pct":[-0.5697818855762361,0.7246336772648757],"prob_bootstrap_mean_positive":0.6029,"beta":0.06893024137823132,"annual_intercept_pct":-0.5314081317033434,"r2":0.018842372391656648,"daily_vol_pct":7.529541246816993,"day_trades":28,"max_day_trades_five_sessions":3,"simulation_sessions":19,"terminal_pct":[-2.7706537761048318,0.004678025517312889,3.3956805176529326],"dollars_full_fund":[-6.807219262511961,0.011493440893486037,8.34284746382149],"loss_prob":0.4063,"maxdd95_pct":3.662768645120329,"exit_counts":{"stop":49,"gap_stop":32,"gap_target":28,"target":24},"years":{"2023":3.2481781286806344,"2024":-2.0772055478591067,"2025":6.001770233389769,"2026":-4.384837398870056}}
https://runway.adityaperswal.workers.dev/data/stock-bars
Country monthly dependence and simulation full output
Quant replication2026-09-05 02:20
Measured Sep5, scripts stats.py and registered fixed strategy. Bootstrap frequencies not live probabilities, 19-session scenario not exact month-end forecast. {"month_clusters":44,"mean_ci95_pct":[0.21095961270398453,3.5098230778016943],"prob_bootstrap_mean_positive":0.9876,"beta":0.9381773003048807,"annual_intercept_pct":3.0012911931430293,"r2":0.3870264825568581,"daily_vol_pct":22.61210992541968,"day_trades":0,"max_day_trades_five_sessions":0,"simulation_sessions":19,"terminal_pct":[-6.498618568691904,1.4031052559905666,11.456242730457559],"dollars_full_fund":[-15.966455961419138,3.447289303443223,28.146842764461177],"loss_prob":0.3807,"maxdd95_pct":11.376718729511737,"exit_counts":{"month":130},"years":{"2023":14.827918232914383,"2024":-8.256243678194696,"2025":40.23443093311017,"2026":44.37175334429728}}
https://runway.adityaperswal.workers.dev/data/stock-bars